F uchs endothelial corneal dystrophy (FECD) is a genetically complex, age-related disorder that affects 4.5% of individuals older than 50 years and 10.5% of patients older than 60 years. 1 It leads to progressive loss of corneal endothelial cells and extracellular deposits, termed guttae. These developments compromise corneal deturgescence, resulting in swelling and loss of vision. [2] [3] [4] Stromal edema may also correlate with keratocyte depletion of the anterior cornea. 5 The clinical course of FECD usually spans 10 to 20 years. 6 During this time, guttae formation and endothelial changes start in the central cornea and spread toward the periphery. 7 In early stages, FECD is characterized by central guttae accompanied by a decline in the central endothelial cell count (ECC) and morphological changes in the endothelial monolayer. 7 In later stages, coalescence of guttae is accompanied by low central endothelial cell density and compromise in the endothelial barrier function, causing corneal edema. Correspondingly, the area of guttae is significantly larger in the central cornea than in paracentral and peripheral regions. 8 Clinical grading of FECD severity is often determined by slit-lamp microscopy, central corneal thickness (CCT), and central ECC. Slit-lamp grading evaluates the area of guttae coalescence and the presence of edema. 6 An additional method used to determine severity is retroillumination photography, 9,10 which has been used to detect formation of new guttae over time. 11 However, manual counting can be time consuming. Moreover, the main limitation of the central ECC is that in moderate-to-severe FECD, guttae replace the central endothelial monolayer and render the central ECC undetectable by most imaging modalities. 12 As such, central endothelial changes do not significantly correlate with the disease grade in patients with grade 3 or higher (using a modified Krachmer grading scale). 12 To the best of our knowledge, the peripheral ECC has not been studied as a marker of FECD severity in advanced cases.
In vivo confocal microscopy (IVCM) allows for a magnified view of all layers of the cornea, including the endothelium. 13, 14 IVCM can be useful in the evaluation of advanced FECD before grafting as it is able to focus on the posterior cornea despite opacification and edema. 14 Furthermore, confocal microscopy is able to image the peripheral corneal endothelium circumferentially. 15 In this study, we used Heidelberg retina tomograph (HRT) IVCM to detect the relationship between the peripheral ECC and known clinical parameters that are currently used to denote FECD severity. We determined that the peripheral ECC highly correlates with disease severity in advanced FECD, thus introducing a new imaging-based method to assess the clinical progression of FECD.
MATERIALS AND METHODS

Study Population and Data Collection
Approval for this retrospective chart review was obtained from the Institutional Review Board at Massachusetts Eye and Ear Infirmary (Boston, MA). The investigators recorded data in such a manner that subjects could not be identified, either directly or through linked identifiers.
We identified all patients with FECD examined at any point between January 1, 2013, and September 1, 2016, by a cornea specialist (U.V.J.). The electronic medical records and IVCM imaging results (including dates before January 1, 2013) of the patients were reviewed to include only those patients with IVCM performed on the same day as the clinic visit and with IVCM studies including high-quality central and peripheral endothelial imaging. Patients were excluded from this study if IVCM image quality was poor in central or peripheral endothelial photographs or if the patient did not have a complete clinical examination on the same day as IVCM imaging that included refraction, slit-lamp examination, and pachymetry. In cases in which both eyes of a patient qualified for inclusion, both were included for separate analyses. In situations in which a patient had multiple clinic visits in which the required data were available, the most recent date was selected for inclusion in this study.
The laser scanning confocal microscope (HRT3 with Rostock Corneal Module, Heidelberg Engineering, Heidelberg, Germany) was used to obtain endothelial images and to perform manual cell counts centrally and peripherally. HRT3 images that were chosen to determine the ECC for each eye had to be of high resolution and have a countable mosaic of endothelial cells homogenously distributed throughout a scanned area of 400 · 400 mm per image. A region of interest with a minimum area of 0.03 mm 2 was defined on the original image, and the number of cells within that outline was manually counted. In cases of advanced FECD with very few remaining endothelial cells, a representative region of interest was selected to allow for at least a single countable cell, therefore allowing us to quantify a value for the ECC. Subjects were instructed by the imaging technician to look in a direction off-center to obtain a peripheral endothelial photograph, which was captured 2 to 3 mm inside the limbus.
Data collected on each patient included the date of birth, date of the visit, age at the date of the visit, months of follow-up, sex, eye, central ECC, peripheral ECC, directional location of the peripheral ECC, logarithm of the minimum angle of resolution (logMAR) bestcorrected visual acuity (BCVA), clinical grade, CCT, future need for surgery, and type of surgery performed. Clinical grading of FECD was performed at the slit-lamp according to the following guidelines: grade 1-nonconfluent guttae without Descemet folds or clinical thickening; grade 2-presence of any area of confluent guttae without Descemet folds or clinical thickening; grade 3-confluent guttae with Descemet folds or clinical thickening; grade 4-Descemet folds or clinical thickening associated with whitening or haze. For eyes with visual acuity in the counting fingers range, acuity was documented as 20/400 for logMAR conversions. To limit observer bias, the investigator who reviewed electronic medical records (J.A.T.) was different from the researcher who performed manual cell counts using IVCM images (Z.A.S.).
Statistical Analysis
Data were collected and tabulated into an Excel spreadsheet for analysis (Microsoft, Inc, Seattle, WA). Where applicable throughout this article, data are reported as mean 6 SD. Pearson correlation coefficients were used to determine relationships between variables studied. T-tests were used to compare independent mean values within the data. P , 0.05 was considered statistically significant.
RESULTS
Imaging Findings
We identified 154 eyes of 126 patients with FECD that met criteria for inclusion in this study. Eyes were graded from 1 to 4, and imaging from each eye included central and peripheral endothelial photographs. Sample central and peripheral endothelial photographs for eyes of grades 1 through 4 are presented in Figure 1 .
Demographic and Follow-Up Data
Of the 154 eyes, 74 (48.1%) were the right eye and 80 (51.9%) were the left eye. Of the 126 patients, 82 (65.1%) were women and 44 (34.9%) were men. Mean age at the date of the visit was 66.0 6 9.4 years (range 46-88 years). The mean period of follow-up was 29.9 6 19.7 months (range 3-83 months) from the date of the visit. Table 1 presents average age at the date of the visit, percent female, and clinical/imaging features after stratifying by the disease grade. As shown in Table 1 , with the increasing disease grade, the age at the visit date increased. However, this relationship was not statistically significant, although there was a trend toward statistical significance (P = 0.054). The mean disease grade among women was 1.89 6 0.75. The mean disease grade among men was 2.16 6 0.88. This difference was statistically significant (P , 0.05). With higher disease grades, the central ECC and peripheral ECC decreased, visual acuity worsened, and CCT increased (Table  1) . These correlations were all statistically significant (all P , 0.05).
Data Stratified by the Disease Grade
Eyes Requiring Surgery During Follow-Up
A total of 41 eyes eventually required surgery during follow-up. Among women, 17/99 (17.2%) eventually underwent surgery, whereas among men, 24/55 (43.6%) required surgery during follow-up. This difference was statistically significant (P , 0.05). 
Correlations in Advanced Disease Grades
Among eyes with a disease grade of 3 or 4, clinical correlations are presented in Table 2 . Of the 5 variables studied, the peripheral ECC had the highest number of statistically significant correlations with other variables (2 statistically significant correlations). Each of the other variables had 1 or 0 statistically significant correlations. The peripheral ECC was the only variable that significantly correlated with the central ECC and disease grade ( Table 2) .
Correlations in Thickened Corneas
Among eyes with CCT .700 micrometers, clinical correlations are presented in Table 3 . The peripheral ECC demonstrated 3 statistically significant correlations, the highest of the clinical variables studied. The peripheral ECC was the only variable studied that demonstrated a statistically significant relationship with the clinical disease grade (Table 3) .
Correlations in Cases of a Low Central ECC
Among eyes with central ECC ,350 micrometers, correlations are presented in Table 4 . The peripheral ECC had the highest number of statistically significant correlations with other clinical variables. In addition, the peripheral ECC was the only feature that significantly correlated with CCT (Table 4) .
Peripheral ECC According to the Location of the Cell Count
Of the 154 eyes included in this study, peripheral ECC measurements were obtained inferiorly in 29 (18.8%) eyes, nasally in 62 (40.2%) eyes, superiorly in 48 (31.2%) eyes, and temporally in 15 (9.7%) eyes. There was no significant difference when comparing values from the superior and inferior peripheral cornea to the nasal and temporal peripheral cornea (P = 0.859).
DISCUSSION
In this study, we demonstrate that the peripheral ECC is a strong clinical marker of disease severity in advanced FECD, as defined by a high clinical grade, thickened central cornea, or low central ECC. In each of these scenarios, the peripheral ECC was the strongest predictor of disease severity compared with other known markers of FECD progression.
The clinical staging of FECD has been widely explored, and to this day, there is no consensus on the best method to grade this condition. Although slit-lamp grading of the disease is common, agreement between corneal specialists on subjective and morphologic grading in FECD is only moderate. 16 Perhaps the most common subjective measure of disease severity used in FECD is the Krachmer grading system, in which the disease is staged based on slit-lamp findings of the confluence and area of guttae in the central corneal zone. 6 Several objective methods of grading have been developed. The corneal central-to-peripheral thickness ratio is a repeatable, objective measurement that correlates with clinical severity of FECD, and also distinguishes between FECD and normal corneas. 16 Alternatively, effective endothelial cell density (the product of local cell density and the fraction of a confocal image free of guttae) correlates significantly with the subjective grade. 17 CCT has also been shown to correlate directly with FECD severity, although the use of this measure as a substitute for the disease grade is limited by the underlying effect of intraocular pressure, age, and contact lens wear on CCT. 18 Finally, the peripheral guttae ratio may be useful for distinguishing advanced grades of FECD and is another potential method of grading. 12 The Central ECC P , 0.001 P = 0.417 P = 0.09 P = 0.396 Peripheral ECC P , 0.001 P = 0.972 P = 0.003 P = 0.327 logMAR BCVA P = 0.417 P = 0.972 P = 0.286 P = 0.214
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Bold/italic entries are statistically significant (P , 0.05). Central ECC P = 0.028 P = 0.487 P = 0.169 P = 0.001 Peripheral ECC P = 0.028 P = 0.23 P = 0.002 P = 0.008 logMAR BCVA P = 0.487 P = 0.23 P = 0.187 P = 0.875 current findings suggest that the peripheral ECC is a promising imaging-based objective measure of disease severity in advanced cases. The peripheral ECC demonstrated stronger and more correlations with disease severity compared with other disease markers (central ECC, BCVA, clinical disease grade, and CCT). The latter 4 features may be limited in their utility in advanced FECD for a number of reasons. In severe cases of FECD, the central and paracentral endothelia are nearly completely covered by guttae, 12 with peripheral endothelial changes occurring later. 7 As such, central ECC loses its utility as a metric for the disease grade in moderate-to-advanced FECD, as ECC in the central and paracentral zones would not differ across grades. The earlier central degeneration and disorganization of endothelial cells may be secondary to the high density of regenerative endothelial precursor cells in the peripheral cornea. 19, 20 BCVA may be limited as a marker of disease severity in FECD because of the effect of coexisting cataract or retinal pathology. Clinical grading of FECD is limited by its subjectivity, with moderate agreement across specialists. 16 Finally, CCT may be limited because with early central endothelial damage, the central cornea swells primarily and the peripheral cornea remains relatively unaffected until the final stages of FECD. 21 Given that central corneal endothelial cells are essentially obliterated in advanced FECD, the cornea may reach its maximum point of swelling before the final stages of FECD. 22 Interestingly, our findings demonstrated a higher average disease grade in men compared with women, with a higher percentage of men eventually undergoing corneal surgery. These findings parallel those reported in a study by Afshari et al, 23 which found that men were an average of 4 years younger than women at the time of corneal transplantation for FECD and that preoperative corneal thickness was slightly greater in men. To the best of our knowledge, there is no known pathophysiologic mechanism for more rapid FECD progression in men compared with women. The sex disparity identified in our study may be due to the characteristic of men to often present with later ocular disease than women do, and this trend has been previously demonstrated in the case of glaucoma. 24 The value of IVCM in the diagnosis and evaluation of FECD has been previously described. [25] [26] [27] Scanning slit IVCM has been shown to detect changes in the basal epithelium, Bowman layer, anterior stroma, posterior stroma, Descemet membrane, and endothelium in FECD. 25 Furthermore, the ECC obtained by IVCM correlates strongly with counts obtained by standard specular microscopy. 25 IVCM has been proposed as an effective means to study the corneal stroma in cases of FECD in which it may appear clinically normal but has perhaps undergone subclinical changes. 27 In this regard, it may have a role in preoperative evaluation and in evaluating the response of the corneal stroma to endothelial keratoplasty. 27 In advanced cases of FECD, keratoplasty remains the mainstay of treatment. Although penetrating keratoplasty was once the leading surgical treatment for FECD, Descemet membrane endothelial keratoplasty and Descemet stripping endothelial keratoplasty have emerged as the primary methods of treatment. [28] [29] [30] [31] [32] [33] Descemet stripping without endothelial keratoplasty was recently identified as a potential technique in the management of FECD, although further research is needed to understand its clinical applicability. 34 Several weaknesses of this study have been noted. First, we did not measure the exact distance of peripheral ECC measurements from the central axis, and the location of peripheral images may have varied across eyes. However, all images were obtained by 1 of 2 technicians, both of whom practiced very similar techniques. This challenge of measuring the peripheral ECC may affect reproducibility of these results, but we believe that the large number of eyes included in this study likely would minimize the effect of differences because of small displacements in the location of measurements. Second, we obtained a single peripheral ECC in each eye. It has been shown that the inferotemporal cornea is often the most severely damaged area in FECD, possibly because of the lack of protection by the eyelid and nose from ultraviolet light. 35, 36 Furthermore, we know that guttae tend to spread more horizontally than vertically. 37 Thus, the location of the peripheral photograph may have affected the ECC. However, as demonstrated in our results, there was no significant difference between the superior and inferior peripheral cornea and the nasal and temporal peripheral cornea (P = 0.859). Third, logMAR BCVA was used as a measure of disease severity in our study, but the study did not account for decreases in visual potential due to cataract or posterior pathology. For this reason, we used multiple measures of disease severity to allow for a broader picture of disease progression. Finally, although it is important to note agerelated changes in central and peripheral ECC, which could have thus affected our results, we did not find a statistically significant relationship between the grade and age. In addition to the large number of eyes studied in this report, strengths of this study include a single cornea specialist performing all slit-lamp examinations (allowing for consistent grading) and the use of 2 investigators for chart reviews (reducing potential observer bias).
In conclusion, in cases of advanced FECD, severity is best determined by the peripheral ECC compared with the central ECC, BCVA, clinical disease grade, and CCT. The peripheral ECC may be an objective imaging-based marker to monitor FECD progression in severe cases and should be added to the clinical parameters used in evaluating FECD. The peripheral ECC may assist with decisions on when to Grade P = 0.233 P , 0.001 P = 0.003 P = 0.071 CCT P = 0.175 P = 0.035 P = 0.121 P = 0.071
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